Nexcital 5 Tablet
by UniMed UniHealth Pharmaceuticals Ltd
৳8.00
Square Pharmaceuticals Limited
Oxapro 5 from Square Pharmaceuticals & Generic is Escitalopram 5mg. Escitalopram Oxalate is indicated in the treatment of Major depressive episodes, Generalised anxiety disorder, Obsessive-compulsive disorder, Panic disorder with or without agoraphobia & Social anxiety disorder (social phobia).
The use of escitalopram oxalate in the treatment of major depressive episodes is recommended.
Treatment for panic disorder that includes or excludes agoraphobia.
Social anxiety disorder treatment (social phobia).
Generalized anxiety disorder (GAD) is treated.
Obsessive-compulsive disorder treatment.
Escitalopram is a selective serotonin reuptake inhibitor that is taken orally (SSRI). The pure S-enantiomer of the racemic bicyclic phthalate derivative citalopram is escitalopram. When it comes to inhibiting 5-HT reuptake, escitalopram is at least 100 times more potent than the R-enantiomer. Escitalopram binds to serotonergic and other receptors, including alpha, with no or very low affinity.
The safety of daily doses greater than 20 mg has not been established. Escitalopram Oxalate comes in a single daily dose that can be taken with or without food.
The usual dose for major depressive episodes is 10 mg once a day. The dose may be increased to a maximum of 20 mg per day depending on the individual patient's response. To get an antidepressant response, it usually takes 2-4 weeks.
Antidepressants such as SSRIs and related antidepressants should not be started for at least two weeks after stopping an MAOI. An MAOI, on the other hand, should not be started until at least one week after an SSRI or similar antidepressant has been discontinued (2 weeks in the case of paroxetine and sertraline, at least 5 weeks in the case of fluoxetine).
Escitalopram is not recommended for patients who have a known hypersensitivity to Escitalopram, Citalopram, or any of the drug's inactive ingredients. It's not a good idea to take escitalopram and monoamine oxidase/pimozide at the same time.
SSRIs are less sedating than tricyclic antidepressants and have fewer antimuscarinic and cardiotoxic effects. SSRIs can cause gastrointestinal problems (nausea, vomiting, dyspepsia, abdominal pain, diarrhoea, and constipation are all dose-related and fairly common), as well as anorexia and weight loss (increased appetite and weight gain also reported).
The risks and benefits of treating a pregnant woman with Escitalopram during the third trimester should be carefully considered by the physician. It's passed through human breast milk. The risk of citalopram exposure for the infant and the benefits of Escitalopram treatment should be considered when deciding whether to continue or stop nursing or Escitalopram therapy.
In patients with epilepsy (avoid if poorly controlled, discontinue if convulsions develop), concurrent electroconvulsive therapy (prolonged seizures reported with fluoxetine), history of mania, cardiac disease, diabetes mellitus, angle-closure glaucoma, concomitant use of drugs that increase bleeding risk, and history of bleeding disorders, SSRIs should be used with caution.
SSRIs and other antidepressant medications
Protect from light and moisture by storing below 30°C. Keep the medicine out of children's reach.
by Sun Pharmaceutical Industries Ltd.
৳6.50